GRADALIS Trademark

Trademark Overview

On Monday, December 4, 2006, a trademark application was filed for GRADALIS with the United States Patent and Trademark Office. The USPTO has given the GRADALIS trademark a serial number of 77056471. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, March 24, 2020. This trademark is owned by Murex Pharmaceuticals, Inc.. The GRADALIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Evaluation services, namely, providing medical research relating to novel cancer pharmaceuticals; development for others of novel cancer therapeutics
gradalis

General Information

Serial Number77056471
Word MarkGRADALIS
Filing DateMonday, December 4, 2006
Status800 - REGISTERED AND RENEWED
Status DateTuesday, March 24, 2020
Registration Number3763590
Registration DateTuesday, March 23, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 1, 2008

Trademark Statements

Goods and ServicesEvaluation services, namely, providing medical research relating to novel cancer pharmaceuticals; development for others of novel cancer therapeutics
Translation of Words in Mark"GRADALIS" is a Latin term, which generally means a step-by-step endeavor.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 3, 2007
Primary Code042
First Use Anywhere DateWednesday, April 30, 2008
First Use In Commerce DateWednesday, April 30, 2008

Trademark Owner History

Party NameGRADALIS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDallas, TX 75006
Party NameMurex Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDallas, TX 75201
Party NameMurex Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDallas, TX 75201
Party NameMurex Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75201

Trademark Events

Event DateEvent Description
Tuesday, March 24, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, March 24, 2020REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, March 24, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 24, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 28, 2020TEAS SECTION 8 & 9 RECEIVED
Wednesday, January 8, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, March 23, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, February 22, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 22, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 31, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, March 31, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 31, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 2, 2016TEAS SECTION 8 & 15 RECEIVED
Monday, March 23, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 22, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 22, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 29, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 8, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 23, 2010REGISTERED-PRINCIPAL REGISTER
Thursday, February 18, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, January 30, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 5, 2010STATEMENT OF USE PROCESSING COMPLETE
Monday, December 21, 2009USE AMENDMENT FILED
Tuesday, January 5, 2010EXTENSION 3 GRANTED
Monday, December 21, 2009EXTENSION 3 FILED
Monday, December 21, 2009TEAS EXTENSION RECEIVED
Monday, December 21, 2009TEAS STATEMENT OF USE RECEIVED
Wednesday, November 18, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 18, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 24, 2009EXTENSION 2 GRANTED
Wednesday, July 1, 2009EXTENSION 2 FILED
Friday, July 24, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 1, 2009TEAS EXTENSION RECEIVED
Tuesday, December 23, 2008EXTENSION 1 GRANTED
Tuesday, December 23, 2008EXTENSION 1 FILED
Tuesday, December 23, 2008TEAS EXTENSION RECEIVED
Tuesday, July 1, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 16, 2008EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, January 15, 2008EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 1, 2008PUBLISHED FOR OPPOSITION
Wednesday, December 12, 2007NOTICE OF PUBLICATION
Tuesday, November 27, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 27, 2007ASSIGNED TO LIE
Wednesday, October 24, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 3, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 3, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 3, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 5, 2007NON-FINAL ACTION MAILED
Wednesday, April 4, 2007NON-FINAL ACTION WRITTEN
Wednesday, March 28, 2007ASSIGNED TO EXAMINER
Thursday, December 7, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

gradalis novel cancer pharmaceuticals others therapeutics development relating namely services providing